Polish biotech company specializing in the production of human insulin, offering both APIs and finished dosage forms like pre-filled syringes and vials. As a CDMO, Bioton provides comprehensive services, including product development, contract manufacturing, and quality control, all adhering to cGMP and QbD standards. The company’s expertise lies in developing and producing high-quality biopharmaceuticals tailored to client needs. With advanced infrastructure, Bioton supports projects from R&D to commercial production.